These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11019955)

  • 1. Control of oral anticoagulant therapy with whole blood prothrombin time devices: the future has begun.
    Tripodi A
    Thromb Haemost; 2000 Sep; 84(3):362-3. PubMed ID: 11019955
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
    van den Besselaar AM
    Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home prothrombin time monitoring: a literature analysis.
    Yang DT; Robetorye RS; Rodgers GM
    Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime.
    Tripodi A; Chantarangkul V; Bressi C; Mannucci PM
    Am J Clin Pathol; 2003 Feb; 119(2):241-5. PubMed ID: 12579994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point of care monitors for oral anticoagulant therapy.
    Nutescu EA
    Semin Thromb Hemost; 2004 Dec; 30(6):697-702. PubMed ID: 15630676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring oral anticoagulant therapy with point-of-care devices: correlations and caveats.
    Gosselin RC; Owings JT; Larkin E; White RH; Hutchinson R; Branch J
    Clin Chem; 1997 Sep; 43(9):1785-6. PubMed ID: 9299978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of a new chromogenic method for measuring prothrombin time in the control of oral anticoagulant therapy].
    Colla G; Corciulo G
    Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2025-31. PubMed ID: 6525255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoaguChek point-of-care testing prothrombin time monitors.
    Braun SL
    Am J Clin Pathol; 2007 Oct; 128(4):671-2; author reply 672. PubMed ID: 17924500
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of plasmas from donors under oral anticoagulant treatment for the expression of INR values.
    Moritz B; Lang H
    Haematologica; 1997; 82(5):630-3. PubMed ID: 9407737
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of the performance verification of the CoaguChek XS system.
    Plesch W; Wolf T; Breitenbeck N; Dikkeschei LD; Cervero A; Perez PL; van den Besselaar AM
    Thromb Res; 2008; 123(2):381-9. PubMed ID: 18585761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

  • 12. Standardization of the prothrombin time for monitoring orally administered anticoagulant therapy with use of the international normalized ratio system.
    Nichols WL; Bowie EJ
    Mayo Clin Proc; 1993 Sep; 68(9):897-8. PubMed ID: 8371608
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR system.
    Gardiner C; Longair I; Hills J; Cohen H; Mackie IJ; Machin SJ
    Am J Clin Pathol; 2008 Mar; 129(3):500-4. PubMed ID: 18285276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary whole blood testing by a new portable monitor. Comparison with standard determination of the international normalized ratio.
    de Miguel D; Burgaleta C; Reyes E; Pascual T
    Am J Clin Pathol; 2003 Jul; 120(1):28-33. PubMed ID: 12866369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of prothrombin time in patients on oral anticoagulant therapy: effect of two different evacuated tubes.
    D'Angelo G; Villa C
    Haematologica; 1999 Jul; 84(7):656-7. PubMed ID: 10406912
    [No Abstract]   [Full Text] [Related]  

  • 17. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different sensitivities of various thromboplastins to two blood collection systems for monitoring oral anticoagulant therapy.
    van den Besselaar AM; Bertina RM; van der Meer FJ; den Hartigh J
    Thromb Haemost; 1999 Jul; 82(1):153-4. PubMed ID: 10456474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.